Inhibitor Therapeutics, Inc. - 8-K Filing
Inhibitor Therapeutics held its 2026 Annual Meeting of Stockholders on September 15, 2026 and elected directors, ratified auditors, approved an incentive plan, executive compensation, and set the frequency for future advisory votes. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 is incorporated by reference in this Item 5)
Tickers: $INTI